COPD patients with ventilator-associated pneumonia: implications for management

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 12, 2015, Pages 2403-2411

  Koulenti, D ^a,b   Blot, S ^b,c   Dulhunty, J M ^b,d   Papazian, L ^e   Martin Loeches, I ^f,g,n   Dimopoulos, G ^a   Brun Buisson, C ^h   Nauwynck, M ⁱ   Putensen, C ^j   Sole Violan, J ^k   Armaganidis, A ^a   Rello, J ^l,m,n  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GHENT UNIVERSITY   (Belgium)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e AIX MARSEILLE UNIVERSITY   (France)

^f Servicio de Oncología Médica   (Spain)

^g MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^h Henri Mondor University Hospital   (France)

ⁱ General Hospital St Jan   (Belgium)

^j UNIVERSITY HOSPITAL BONN   (Germany)

^k HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁿ INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SECONDARY ANALYSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; VENTILATOR ASSOCIATED PNEUMONIA; COMPLICATION; EUROPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ANTIINFECTIVE AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; EUROPE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84947869748     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2495-6     Document Type: Article

References (40)

1. Lorente L, Blot S, Rello J (2010) New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 182:870–876. doi:10.1164/rccm.201001-0081CI
2. Blot S, Rello J, Vogelaers D (2011) What is new in the prevention of ventilator-associated pneumonia? Curr Opin Pulm Med 17:155–159. doi:10.1097/MCP.0b013e328344db65
3. Nair GB, Niederman MS (2015) Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med 41:34–48. doi:10.1007/s00134-014-3564-5
4. Safdar N, Dezfulian C, Collard HR, Saint S (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33:2184–2193
5. Kanafani ZA, Kara L, Hayek S, Kanj SS (2003) Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect Control Hosp Epidemiol 24:864–869. doi:10.1086/502151
6. Rodriguez JL, Gibbons KJ, Bitzer LG, Dechert RE, Steinberg SM, Flint LM (1991) Pneumonia: incidence, risk factors, and outcome in injured patients. J Trauma 31:907–912, discussion 912–4
7. Restrepo MI, Anzueto A, Arroliga AC et al (2010) Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol 31:509–515. doi:10.1086/651669
8. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416. doi:10.1164/rccm.200405-644ST
9. Muscedere JG, Martin CM, Heyland DK (2008) The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 23:5–10. doi:10.1016/j.jcrc.2007.11.012
10. Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681. doi:10.1007/s00134-012-2808-5
11. Myny D, Depuydt P, Colardyn F, Blot S (2005) Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin Belg 60:114–121. doi:10.1179/acb.2005.022
12. Pauwels RA, Buist AS, Calverley PM et al (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256–1276
13. Decramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet 379:1341–1351. doi:10.1016/S0140-6736(11)60968-9
14. (2015) From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available online at: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed 28 Apr 2015
15. Crim C, Calverley PMA, Anderson JA et al (2009) Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 34:641–647. doi:10.1183/09031936.00193908
16. Ernst P, Gonzalez AV, Brassard P, Suissa S (2007) Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 176:162–166. doi:10.1164/rccm.200611-1630OC
17. Myles PR, McKeever TM, Pogson Z, Smith CJ, Hubbard RB (2009) The incidence of pneumonia using data from a computerized general practice database. Epidemiol Infect 137:709–716. doi:10.1017/S0950268808001428
18. Vinogradova Y, Hippisley-Cox J, Coupland C (2009) Identification of new risk factors for pneumonia: population-based case–control study. Br J Gen Pract 59:e329–e338. doi:10.3399/bjgp09X472629
19. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A (2006) COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28:346–351. doi:10.1183/09031936.06.00131905
20. Rello J, Rodriguez A, Torres A et al (2006) Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27:1210–1216. doi:10.1183/09031936.06.00139305
21. Molinos L, Clemente MG, Miranda B et al (2009) Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 58:417–424. doi:10.1016/j.jinf.2009.03.003
22. Restrepo MI, Mortensen EM, Anzueto A (2011) Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Eur Respir J 38:1–3. doi:10.1183/09031936.00028711
23. Snijders D, van der Eerden M, de Graaff C, Boersma W (2010) The influence of COPD on mortality and severity scoring in community-acquired pneumonia. Respiration 79:46–53. doi:10.1159/000213757
24. Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A (2007) Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 101:2139–2144. doi:10.1016/j.rmed.2007.05.011
25. Nseir S, Di Pompeo C, Soubrier S et al (2005) Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 128:1650–1656. doi:10.1378/chest.128.3.1650
26. Koulenti D, Lisboa T, Brun-Buisson C et al (2009) Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 37:2360–2368. doi:10.1097/CCM.0b013e3181a037ac
27. McCabe WR, Jackson GG (1962) Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 110:847–855
28. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
29. [No authors listed] (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874
30. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
31. von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573–577
32. Magret M, Amaya-Villar R, Garnacho J et al (2010) Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study. J Trauma 69:849–854. doi:10.1097/TA.0b013e3181e4d7be
33. Cook A, Norwood S, Berne J (2010) Ventilator-associated pneumonia is more common and of less consequence in trauma patients compared with other critically ill patients. J Trauma 69:1083–1091. doi:10.1097/TA.0b013e3181f9fb51
34. Xie D-S, Xiong W, Lai R-P et al (2011) Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey. J Hosp Infect 78:284–288. doi:10.1016/j.jhin.2011.03.009
35. Al-Dorzi HM, El-Saed A, Rishu AH et al (2012) The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control 40:794–799. doi:10.1016/j.ajic.2011.10.004
36. Tejerina E, Frutos-Vivar F, Restrepo MI et al (2006) Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 21:56–65. doi:10.1016/j.jcrc.2005.08.005
37. Rodríguez A, Lisboa T, Solé-Violán J et al (2011) Impact of nonexacerbated COPD on mortality in critically ill patients. Chest 139:1354–1360. doi:10.1378/chest.10-2439
38. Rello J, Ausina V, Ricart M et al (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20:193–198
39. Rello J, Borgatta B, Lisboa T (2013) Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century. Intensive Care Med 39:2204–2206. doi:10.1007/s00134-013-3046-1
40. Makris D, Desrousseaux B, Zakynthinos E, Durocher A, Nseir S (2011) The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia. Respir Med 105(7):1022–1029